hyperphosphatemia

You have accessRestricted Access
Parathyroidectomy in the Management of Secondary Hyperparathyroidism
Wei Ling Lau, Yoshitsugu Obi and Kamyar Kalantar-Zadeh

CJASN June 2018, 13 (6) 952-961; DOI: https://doi.org/10.2215/CJN.10390917

Add to Selected Citations
You have accessRestricted Access
The Effect of Extended Release Niacin on Markers of Mineral Metabolism in CKD
Rakesh Malhotra, Ronit Katz, Andrew Hoofnagle, Andrew Bostom, Dena E. Rifkin, Ruth Mcbride, Jeffrey Probstfield, Geoffrey Block and Joachim H. Ix

CJASN January 2018, 13 (1) 36-44; DOI: https://doi.org/10.2215/CJN.05440517

Add to Selected Citations
You have accessRestricted Access
Lowering Expectations with Niacin Treatment for CKD-MBD
Tilman B. Drüeke and Ziad A. Massy

CJASN January 2018, 13 (1) 6-8; DOI: https://doi.org/10.2215/CJN.12021017

Add to Selected Citations
You have accessRestricted Access
Continued Search for Therapies to Favorably Modify Phosphate and FGF23 Levels in CKD
Rupal Mehta and Tamara Isakova

CJASN December 2017, 12 (12) 1911-1913; DOI: https://doi.org/10.2215/CJN.11011017

Add to Selected Citations
You have accessRestricted Access
Initiation of Sevelamer and Mortality among Hemodialysis Patients Treated with Calcium-Based Phosphate Binders
Hirotaka Komaba, Mia Wang, Masatomo Taniguchi, Suguru Yamamoto, Takanobu Nomura, Douglas E. Schaubel, Abigail R. Smith, Jarcy Zee, Angelo Karaboyas, Brian Bieber, Masafumi Fukagawa and Francesca Tentori

CJASN September 2017, 12 (9) 1489-1497; DOI: https://doi.org/10.2215/CJN.13091216

Add to Selected Citations
You have accessRestricted Access
Two phosphAte taRGets in End-stage renal disease Trial (TARGET): A Randomized Controlled Trial
Ron Wald, Christian G. Rabbat, Louis Girard, Amit X. Garg, Karthik Tennankore, Jessica Tyrwhitt, Andrew Smyth, Andrea Rathe-Skafel, Peggy Gao, Andrea Mazzetti, Jackie Bosch, Andrew T. Yan, Patrick Parfrey, Braden J. Manns and Michael Walsh

CJASN June 2017, 12 (6) 965-973; DOI: https://doi.org/10.2215/CJN.10941016

Add to Selected Citations
You have accessRestricted Access
Association of Serum Phosphorus Concentration with Mortality and Graft Failure among Kidney Transplant Recipients
Hee Jung Jeon, Yong Chul Kim, Seokwoo Park, Clara Tammy Kim, Jongwon Ha, Duck Jong Han, Jieun Oh, Chun Soo Lim, In Mok Jung, Curie Ahn, Yon Su Kim, Jung Pyo Lee and Young Hoon Kim

CJASN April 2017, 12 (4) 653-662; DOI: https://doi.org/10.2215/CJN.07090716

Add to Selected Citations
You have accessRestricted Access
Phosphate Toxicity in CKD: The Killer among Us
Cynthia S. Ritter and Eduardo Slatopolsky

CJASN June 2016, 11 (6) 1088-1100; DOI: https://doi.org/10.2215/CJN.11901115

Add to Selected Citations
You have accessRestricted Access
Mineral Metabolism in European Children Living with a Renal Transplant: A European Society for Paediatric Nephrology/European Renal Association–European Dialysis and Transplant Association Registry Study
Marjolein Bonthuis, Marco Busutti, Karlijn J. van Stralen, Kitty J. Jager, Sergey Baiko, Sevcan Bakkaloğlu, Nina Battelino, Maria Gaydarova, Bruno Gianoglio, Paloma Parvex, Clara Gomes, James G. Heaf, Ludmila Podracka, Dafina Kuzmanovska, Maria S. Molchanova, Tatiana E. Pankratenko, Fotios Papachristou, György Reusz, Maria José Sanahuja, Rukshana Shroff, Jaap W. Groothoff, Franz Schaefer and Enrico Verrina

CJASN May 2015, 10 (5) 767-775; DOI: https://doi.org/10.2215/CJN.06200614

Add to Selected Citations
Open Access
The Effect of Cinacalcet on Calcific Uremic Arteriolopathy Events in Patients Receiving Hemodialysis: The EVOLVE Trial
Jürgen Floege, Yumi Kubo, Anna Floege, Glenn M. Chertow and Patrick S. Parfrey

CJASN May 2015, 10 (5) 800-807; DOI: https://doi.org/10.2215/CJN.10221014

Add to Selected Citations

Main menu

User menu

Search

hyperphosphatemia

About

Author Information

More information